SAN DIEGO--(BUSINESS WIRE)--Aethlon Medical, Inc. (OTCBB:AEMD) announced today that its Chief Science Officer, Dr. Richard H. Tullis will give a clinical presentation of the Aethlon Hemopurifier® at the 11th International Conference on Dialysis on January 29th. The presentation will review treatment outcomes of dialysis patients infected with Hepatitis-C (HCV), and will discuss the additional use of the Hemopurifier® in HIV and Cancer care. The conference will be held at Caesars Palace in Las Vegas, Nevada. Additional information, including the speaker agenda, can be accessed online at: http://www.renalresearch.com.
